| (84) |
Benannte Vertragsstaaten: |
|
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL
NO PL PT RO RS SE SI SK SM TR |
| (43) |
Veröffentlichungstag der Anmeldung: |
|
24.12.2014 Patentblatt 2014/52 |
| (73) |
Patentinhaber: Ivoclar Vivadent AG |
|
9494 Schaan (LI) |
|
| (72) |
Erfinder: |
|
- Moszner, Norbert
LI-9493 Mauren (LI)
- Catel, Yohann
CH-9470 Buchs (CH)
- Bock, Thorsten
AT-6800 Feldkirch (AT)
|
| (74) |
Vertreter: Uexküll & Stolberg |
|
Partnerschaft von
Patent- und Rechtsanwälten mbB
Beselerstraße 4
22607 Hamburg
22607 Hamburg (DE) |
| (56) |
Entgegenhaltungen: :
EP-A1- 1 057 468
US-A- 6 160 015
|
DE-A1- 19 918 974
US-A1- 2005 048 398
|
|
| |
|
|
- NO, JOO HWAN ET AL: "Lipophilic analogs of zoledronate and risedronate inhibit Plasmodium
geranylgeranyl diphosphate synthase (GGPPS) and exhibit potent antimalarial activity",
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, Bd.
109, Nr. 11, 2012, Seiten 4058-4063, XP002713050, ISSN: 0027-8424
- NORMAN, DEREK D. ET AL: "Autotaxin inhibition: Development and application of computational
tools to identify site-selective lead compounds", BIOORGANIC & MEDICINAL CHEMISTRY,
Bd. 21, Nr. 17, 2013, Seiten 5548-5560, XP002713051, ISSN: 0968-0896 -& NORMAN, DEREK
D. ET AL: "Supporting Information:Autotaxin inhibition: Development and application
of computational tools to identify site-selective lead compounds", BIOORGANIC & MEDICINAL
CHEMISTRY, Seiten S1-S21, XP002713891,
|
|
